Investor Login
Investment Focus

DRI Capital, through its managed private equity funds, seeks to invest in royalty entitlements on healthcare products which are safe, efficacious and medically necessary. DRI Capital’s focus is on products that treat chronic, critical and/or rare diseases and which improve the health and quality of a patient’s life. In addition to the traditional focus on pharmaceutical products, DRI Capital considers investments in royalty entitlements on medical devices, diagnostic products and life science tools and technologies. Products DRI Capital invests in must be either approved by a major regulatory body or in late stage clinical development.